Search results
Moderna Wins FDA Approval For Second-Ever Product; Why Its RSV Vaccine Could Dominate Pfizer, GSK
Investor's Business Daily· 5 days agoAfter a median follow-up time of 112 days — roughly...shot proved 83.7% effective against lower...
Is Moderna Stock A Buy As The U.S. Government Mulls Its Bird Flu Vaccine?
Investor's Business Daily· 5 days agoMeanwhile, investors are closely watching for Food and Drug Administration approval of Moderna's RSV...
Moderna wins second product approval with RSV vaccine
Market Watch· 5 days agoModerna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory...
How Moderna’s newly approved RSV vaccine could impact 2024 revenue - Boston Business Journal
The Business Journals· 2 days agoThe RSV vaccine will now be reviewed at the CDC's Advisory Committee on Immunization Practices...
FDA approves Moderna’s mRNA RSV vaccine for older adults | CNN
CNN.com· 5 days agoThe US Food and Drug Administration has approved another vaccine to help protect older people from...
The chicken and egg problem of fighting another flu pandemic
Salon via Yahoo News· 4 days agoModerna have had to destroy hundreds of millions of doses of unwanted vaccine as public interest...
Bird Flu Confirmed in Third Farmworker. It’s the First Case With Respiratory Symptoms.
Barrons.com· 6 days agoThey also said they were in discussions with Moderna and Pfizer about making avian influenza ...
New U.S. bird-flu case is first with respiratory symptoms, CDC says
Morningstar· 6 days agoA new human bird-flu case identified in a Michigan dairy worker is the first in the U.S. to involve acute respiratory symptoms, the Centers for Disease Control and Prevention ...